| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.13B | 13.28B | 13.09B | 14.16B | 13.91B | 14.29B |
| Gross Profit | 4.46B | 4.52B | 4.42B | 4.64B | 4.51B | 4.45B |
| EBITDA | 2.01B | 1.81B | 1.83B | 1.75B | 1.79B | 1.74B |
| Net Income | 708.56M | 765.33M | 797.07M | 723.94M | 755.92M | 760.11M |
Balance Sheet | ||||||
| Total Assets | 31.62B | 31.74B | 32.44B | 30.88B | 31.33B | 31.28B |
| Cash, Cash Equivalents and Short-Term Investments | 4.57B | 4.55B | 4.64B | 4.43B | 5.03B | 5.06B |
| Total Debt | 12.57B | 12.55B | 13.70B | 12.62B | 13.39B | 13.51B |
| Total Liabilities | 14.55B | 14.67B | 15.85B | 14.74B | 15.53B | 15.51B |
| Stockholders Equity | 17.06B | 17.07B | 16.59B | 16.14B | 15.80B | 15.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.19B | -1.02B | 645.18M | 844.58M | 1.27B |
| Operating Cash Flow | 0.00 | 2.71B | 793.95M | 1.29B | 1.60B | 2.36B |
| Investing Cash Flow | 0.00 | -1.44B | -1.13B | -903.58M | -446.41M | -877.62M |
| Financing Cash Flow | 0.00 | -1.30B | 653.01M | -1.17B | -869.55M | -338.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥43.56B | 4.48 | ― | 3.01% | -1.93% | 47.35% | |
74 Outperform | ¥42.26B | 6.89 | ― | 3.86% | 14.97% | 72.48% | |
73 Outperform | ¥6.44B | 11.79 | 2.90% | 4.53% | -15.55% | -41.48% | |
73 Outperform | ¥3.42T | 9.18 | 11.39% | 2.93% | 1.93% | 5.42% | |
69 Neutral | ¥57.93B | 4.43 | ― | 6.02% | 1.33% | 9.59% | |
68 Neutral | ¥56.06B | 6.36 | 6.98% | 7.35% | -21.50% | -56.82% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |